Purpose: The aim of this study was to systematically analyze the prescription trends of medical narcotic appetite suppressants in South Korea.
Materials and methods: Data was extracted from the Narcotics Information Management System dataset from 2020, which encompasses nationwide information concerning the use of medical narcotics. The selected variables for this study included the types of prescribed medical narcotic appetite suppressants, gender, age, region, and the category of medical institution. Regional prescription trends were compared by utilizing the defined daily doses for statistical purposes (S-DDD).
Results: The prescription of medical narcotic appetite suppressants was predominantly for females (94%), with the highest prescription rates identified in the 30-40 age group. The majority of these prescriptions were dispensed by clinics. Within the category of narcotic appetite suppressants, phentermine and phendimetrazine were found to have higher prescription rates. Notably, the region of Daegu recorded the highest S-DDD value (12.66) in phentermine consumption.
Conclusion: Our findings underscore the need for governmental policy and guidance to address the risks linked to the long-term use of medical narcotic appetite suppressants. This is crucial to ensure their safe and efficacious prescription and administration.
{"title":"Analysis of Prescription Trends for Narcotic Appetite Suppressants: Utilizing the Narcotics Information Management System.","authors":"Kyung Sun Oh, Euna Han","doi":"10.3349/ymj.2023.0335","DOIUrl":"10.3349/ymj.2023.0335","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to systematically analyze the prescription trends of medical narcotic appetite suppressants in South Korea.</p><p><strong>Materials and methods: </strong>Data was extracted from the Narcotics Information Management System dataset from 2020, which encompasses nationwide information concerning the use of medical narcotics. The selected variables for this study included the types of prescribed medical narcotic appetite suppressants, gender, age, region, and the category of medical institution. Regional prescription trends were compared by utilizing the defined daily doses for statistical purposes (S-DDD).</p><p><strong>Results: </strong>The prescription of medical narcotic appetite suppressants was predominantly for females (94%), with the highest prescription rates identified in the 30-40 age group. The majority of these prescriptions were dispensed by clinics. Within the category of narcotic appetite suppressants, phentermine and phendimetrazine were found to have higher prescription rates. Notably, the region of Daegu recorded the highest S-DDD value (12.66) in phentermine consumption.</p><p><strong>Conclusion: </strong>Our findings underscore the need for governmental policy and guidance to address the risks linked to the long-term use of medical narcotic appetite suppressants. This is crucial to ensure their safe and efficacious prescription and administration.</p>","PeriodicalId":23765,"journal":{"name":"Yonsei Medical Journal","volume":"65 8","pages":"480-487"},"PeriodicalIF":2.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11284301/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Han Kyu Na, Jeong-Hyeon Shin, Sung-Woo Kim, Seongho Seo, Woo-Ram Kim, Jae Myeong Kang, Sang-Yoon Lee, Jaelim Cho, Justin Byun, Nobuyuki Okamura, Joon-Kyung Seong, Young Noh
Purpose: Alzheimer's disease (AD) dementia may not be a single disease entity. Early-onset AD (EOAD) and late-onset AD (LOAD) have been united under the same eponym of AD until now, but disentangling the heterogeneity according to the age of sonset has been a major tenet in the field of AD research.
Materials and methods: Ninety-nine patients with AD (EOAD, n=54; LOAD, n=45) and 66 cognitively normal controls completed both [18F]THK5351 and [18F]flutemetamol (FLUTE) positron emission tomography scans along with structural magnetic resonance imaging and detailed neuropsychological tests.
Results: EOAD patients had higher THK retention in the precuneus, parietal, and frontal lobe, while LOAD patients had higher THK retention in the medial temporal lobe. Intravoxel correlation analyses revealed that EOAD presented narrower territory of local FLUTE-THK correlation, while LOAD presented broader territory of correlation extending to overall parieto-occipito-temporal regions. EOAD patients had broader brain areas which showed significant negative correlations between cortical thickness and THK retention, whereas in LOAD, only limited brain areas showed significant correlation with THK retention. In EOAD, most of the cognitive test results were correlated with THK retention. However, a few cognitive test results were correlated with THK retention in LOAD.
Conclusion: LOAD seemed to show gradual increase in tau and amyloid, and those two pathologies have association to each other. On the other hand, in EOAD, tau and amyloid may develop more abruptly and independently. These findings suggest LOAD and EOAD may have different courses of pathomechanism.
{"title":"Diverging Relationships among Amyloid, Tau, and Brain Atrophy in Early-Onset and Late-Onset Alzheimer's Disease.","authors":"Han Kyu Na, Jeong-Hyeon Shin, Sung-Woo Kim, Seongho Seo, Woo-Ram Kim, Jae Myeong Kang, Sang-Yoon Lee, Jaelim Cho, Justin Byun, Nobuyuki Okamura, Joon-Kyung Seong, Young Noh","doi":"10.3349/ymj.2023.0308","DOIUrl":"10.3349/ymj.2023.0308","url":null,"abstract":"<p><strong>Purpose: </strong>Alzheimer's disease (AD) dementia may not be a single disease entity. Early-onset AD (EOAD) and late-onset AD (LOAD) have been united under the same eponym of AD until now, but disentangling the heterogeneity according to the age of sonset has been a major tenet in the field of AD research.</p><p><strong>Materials and methods: </strong>Ninety-nine patients with AD (EOAD, n=54; LOAD, n=45) and 66 cognitively normal controls completed both [<sup>18</sup>F]THK5351 and [<sup>18</sup>F]flutemetamol (FLUTE) positron emission tomography scans along with structural magnetic resonance imaging and detailed neuropsychological tests.</p><p><strong>Results: </strong>EOAD patients had higher THK retention in the precuneus, parietal, and frontal lobe, while LOAD patients had higher THK retention in the medial temporal lobe. Intravoxel correlation analyses revealed that EOAD presented narrower territory of local FLUTE-THK correlation, while LOAD presented broader territory of correlation extending to overall parieto-occipito-temporal regions. EOAD patients had broader brain areas which showed significant negative correlations between cortical thickness and THK retention, whereas in LOAD, only limited brain areas showed significant correlation with THK retention. In EOAD, most of the cognitive test results were correlated with THK retention. However, a few cognitive test results were correlated with THK retention in LOAD.</p><p><strong>Conclusion: </strong>LOAD seemed to show gradual increase in tau and amyloid, and those two pathologies have association to each other. On the other hand, in EOAD, tau and amyloid may develop more abruptly and independently. These findings suggest LOAD and EOAD may have different courses of pathomechanism.</p>","PeriodicalId":23765,"journal":{"name":"Yonsei Medical Journal","volume":"65 8","pages":"434-447"},"PeriodicalIF":2.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11284308/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mijung Kim, Yun Jung Kim, Young Seok Kim, Tai Suk Roh, Eun-Ju Lee, Jin-Hyung Shim, Eun Hye Kang, Min Ji Kim, In Sik Yun
Purpose: External ear reconstruction has been a challenging subject for plastic surgeons for decades. Popular methods using autologous costal cartilage or polyethylene still have their drawbacks. With the advance of three-dimensional (3D) printing technique, bioscaffold engineering using synthetic polymer draws attention as an alternative. This is a clinical trial of ear reconstruction using 3D printed scaffold, presented with clinical results after 1 year.
Materials and methods: From 2021 to 2022, five adult patients with unilateral microtia underwent two-staged total ear reconstruction using 3D printed implants. For each patient, a patient-specific 3D printed scaffold was designed and produced with polycaprolactone (PCL) based on computed tomography images, using fused deposition modeling. Computed tomography scan was obtained preoperatively, within 2 weeks following the surgery and after 1 year, to compare the volume of the normal side and the reconstructed ear. At 1-year visit, clinical photo was taken for scoring by two surgeons and patients themselves.
Results: All five patients had completely healed reconstructed ear at 1-year follow-up. On average, the volume of reconstructed ear was 161.54% of that of the normal side ear. In a range of 0 to 10, objective assessors gave scores 3 to 6, whereas patients gave scores 8 to 10.
Conclusion: External ear reconstruction using 3D printed PCL implant showed durable, safe results reflected by excellent volume restoration and patient satisfaction at 1 year postoperatively. Further clinical follow-up with more cases and refinement of scaffold with advancing bioprinting technique is anticipated. The study's plan and results have been registered with the Clinical Research Information Service (CRIS No. 3-2019-0306) and the Ministry of Food and Drug Safety (MFDS No. 1182).
目的:几十年来,外耳重建一直是整形外科医生面临的挑战。使用自体肋软骨或聚乙烯的流行方法仍有其缺点。随着三维(3D)打印技术的发展,使用合成聚合物的生物支架工程作为一种替代方法备受关注。这是一项使用三维打印支架进行耳部重建的临床试验,展示了一年后的临床结果:从 2021 年到 2022 年,5 名单侧小耳畸形的成年患者接受了两阶段的全耳重建手术,使用的是 3D 打印植入物。根据计算机断层扫描图像,使用熔融沉积建模技术为每位患者设计并制作了患者专用的聚己内酯(PCL)3D 打印支架。术前、术后两周内和一年后分别进行计算机断层扫描,以比较正常侧和重建耳的体积。一年后,由两名外科医生和患者本人拍摄临床照片进行评分:结果:随访一年时,五名患者的再造耳均已完全愈合。平均而言,再造耳的体积是正常侧耳体积的 161.54%。在0至10分的范围内,客观评估者给出的分数为3至6分,而患者给出的分数为8至10分:结论:使用 3D 打印 PCL 植入体进行外耳再造显示出持久、安全的效果,术后 1 年的容积恢复良好,患者满意度高。随着生物打印技术的不断进步,预计将有更多病例接受进一步的临床随访,并对支架进行改进。该研究的计划和结果已在临床研究信息服务机构(CRIS 编号:3-2019-0306)和食品药品安全部(MFDS 编号:1182)注册。
{"title":"One-Year Results of Ear Reconstruction with 3D Printed Implants.","authors":"Mijung Kim, Yun Jung Kim, Young Seok Kim, Tai Suk Roh, Eun-Ju Lee, Jin-Hyung Shim, Eun Hye Kang, Min Ji Kim, In Sik Yun","doi":"10.3349/ymj.2023.0444","DOIUrl":"10.3349/ymj.2023.0444","url":null,"abstract":"<p><strong>Purpose: </strong>External ear reconstruction has been a challenging subject for plastic surgeons for decades. Popular methods using autologous costal cartilage or polyethylene still have their drawbacks. With the advance of three-dimensional (3D) printing technique, bioscaffold engineering using synthetic polymer draws attention as an alternative. This is a clinical trial of ear reconstruction using 3D printed scaffold, presented with clinical results after 1 year.</p><p><strong>Materials and methods: </strong>From 2021 to 2022, five adult patients with unilateral microtia underwent two-staged total ear reconstruction using 3D printed implants. For each patient, a patient-specific 3D printed scaffold was designed and produced with polycaprolactone (PCL) based on computed tomography images, using fused deposition modeling. Computed tomography scan was obtained preoperatively, within 2 weeks following the surgery and after 1 year, to compare the volume of the normal side and the reconstructed ear. At 1-year visit, clinical photo was taken for scoring by two surgeons and patients themselves.</p><p><strong>Results: </strong>All five patients had completely healed reconstructed ear at 1-year follow-up. On average, the volume of reconstructed ear was 161.54% of that of the normal side ear. In a range of 0 to 10, objective assessors gave scores 3 to 6, whereas patients gave scores 8 to 10.</p><p><strong>Conclusion: </strong>External ear reconstruction using 3D printed PCL implant showed durable, safe results reflected by excellent volume restoration and patient satisfaction at 1 year postoperatively. Further clinical follow-up with more cases and refinement of scaffold with advancing bioprinting technique is anticipated. The study's plan and results have been registered with the Clinical Research Information Service (CRIS No. 3-2019-0306) and the Ministry of Food and Drug Safety (MFDS No. 1182).</p>","PeriodicalId":23765,"journal":{"name":"Yonsei Medical Journal","volume":"65 8","pages":"456-462"},"PeriodicalIF":2.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11284305/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In A Lee, Minji Kim, Jin Kyong Kim, Cho Rok Lee, Sang-Wook Kang, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung
Purpose: Thyroid cancer incidence has increased in recent decades, and thyroid surgery is continuously evolving in response to demands for postoperative comfort and cosmesis. This study aimed to introduce a new surgical method for minimally invasive open bilateral total thyroidectomy (MI-BTT) using a unilateral 2.5-3.0 cm neck incision. Furthermore, we reported the surgical outcomes and postoperative quality of life (QoL) using a validated Korean translated Dermatology Life Quality Index (DLQI) questionnaire.
Materials and methods: We retrospectively evaluated 41 Asian patients who underwent MI-BTT for low-risk papillary thyroid cancer by a single surgeon from March 2019 to December 2021.
Results: A total of 4 male and 37 female patients were included. The mean age and body mass index were 46.2±10.1 years and 23.3±3.3 kg/m², respectively. The average tumor size was 1.1±0.6 cm, and 36 patients (87.8%) had bilateral cancer. Twenty-three (56.1%) patients had occult central lymph node (CLN) metastasis in the final pathologic report, with the mean number of dissected CLNs being 7.2±6.5. Gross capsular extension was found in 6 patients (14.6%). Moreover, 28 patients (68.3%) received additional treatment after surgery with low or high doses of radioactive iodine. The average serum-stimulated thyroglobulin value identified during treatment was 1.57±2.30 ng/mL. The mean operation time was 78.0±13.9 minutes, and postoperative complications included transient hypocalcemia (36.6%), transient hoarseness (24.4%), and seroma (2.4%). The mean total DLQI score was 2.73±0.78, indicating a small effect on QoL.
Conclusion: MI-BTT is a novel, safe, and feasible technique to improve patient satisfaction for surgical scars and QoL.
目的:近几十年来,甲状腺癌的发病率不断上升,甲状腺手术也在不断发展,以满足术后舒适度和美观度的要求。本研究旨在介绍一种采用单侧 2.5-3.0 厘米颈部切口的微创开放式双侧甲状腺全切除术(MI-BTT)的新手术方法。此外,我们还使用经过验证的韩文翻译皮肤科生活质量指数(DLQI)问卷报告了手术效果和术后生活质量(QoL):我们回顾性评估了2019年3月至2021年12月期间由一名外科医生为低危甲状腺乳头状癌接受MI-BTT手术的41名亚洲患者:结果:共纳入4名男性患者和37名女性患者。平均年龄和体重指数分别为(46.2±10.1)岁和(23.3±3.3)kg/m²。肿瘤平均大小为(1.1±0.6)厘米,36 名患者(87.8%)为双侧癌症。23例(56.1%)患者的最终病理报告显示有隐匿性中央淋巴结(CLN)转移,切除的CLN平均数量为(7.2±6.5)个。有 6 名患者(14.6%)发现了毛囊扩展。此外,28 名患者(68.3%)在术后接受了低剂量或高剂量放射性碘的额外治疗。治疗过程中发现的血清刺激甲状腺球蛋白平均值为 1.57±2.30 纳克/毫升。平均手术时间为(78.0±13.9)分钟,术后并发症包括一过性低钙血症(36.6%)、一过性声音嘶哑(24.4%)和血清肿(2.4%)。平均 DLQI 总分为 2.73±0.78,表明对 QoL 的影响较小:结论:MI-BTT 是一种新颖、安全、可行的技术,可提高患者对手术疤痕和 QoL 的满意度。
{"title":"Minimally Invasive Open Bilateral Total Thyroidectomy Using Unilateral Neck Incision in Thyroid Cancer: Preliminary Surgical and Quality of Life Outcomes.","authors":"In A Lee, Minji Kim, Jin Kyong Kim, Cho Rok Lee, Sang-Wook Kang, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung","doi":"10.3349/ymj.2023.0457","DOIUrl":"10.3349/ymj.2023.0457","url":null,"abstract":"<p><strong>Purpose: </strong>Thyroid cancer incidence has increased in recent decades, and thyroid surgery is continuously evolving in response to demands for postoperative comfort and cosmesis. This study aimed to introduce a new surgical method for minimally invasive open bilateral total thyroidectomy (MI-BTT) using a unilateral 2.5-3.0 cm neck incision. Furthermore, we reported the surgical outcomes and postoperative quality of life (QoL) using a validated Korean translated Dermatology Life Quality Index (DLQI) questionnaire.</p><p><strong>Materials and methods: </strong>We retrospectively evaluated 41 Asian patients who underwent MI-BTT for low-risk papillary thyroid cancer by a single surgeon from March 2019 to December 2021.</p><p><strong>Results: </strong>A total of 4 male and 37 female patients were included. The mean age and body mass index were 46.2±10.1 years and 23.3±3.3 kg/m², respectively. The average tumor size was 1.1±0.6 cm, and 36 patients (87.8%) had bilateral cancer. Twenty-three (56.1%) patients had occult central lymph node (CLN) metastasis in the final pathologic report, with the mean number of dissected CLNs being 7.2±6.5. Gross capsular extension was found in 6 patients (14.6%). Moreover, 28 patients (68.3%) received additional treatment after surgery with low or high doses of radioactive iodine. The average serum-stimulated thyroglobulin value identified during treatment was 1.57±2.30 ng/mL. The mean operation time was 78.0±13.9 minutes, and postoperative complications included transient hypocalcemia (36.6%), transient hoarseness (24.4%), and seroma (2.4%). The mean total DLQI score was 2.73±0.78, indicating a small effect on QoL.</p><p><strong>Conclusion: </strong>MI-BTT is a novel, safe, and feasible technique to improve patient satisfaction for surgical scars and QoL.</p>","PeriodicalId":23765,"journal":{"name":"Yonsei Medical Journal","volume":"65 8","pages":"448-455"},"PeriodicalIF":2.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11284307/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hyeon Woo Bae, Yong Joon Lee, Min Young Park, Seung Yoon Yang, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Kang Young Lee, Jae Hee Cheon, Joseph C Carmichael, Byung Soh Min
Purpose: Although advancements in medical treatments have been made, approximately half of patients with intestinal Crohn's disease (CD) require intestinal resections during their lifetime. It is well-known that the nutritional status of CD patients can impact postoperative morbidity. The objective of this study was to evaluate the clinical significance of prognostic nutritional index (PNI) in patients with intestinal CD who underwent primary bowel resection.
Materials and methods: We retrospectively investigated patients who were diagnosed with CD and underwent intestinal surgery at Severance Hospital between January 2005 and October 2018. The patients were divided into two groups: PNI ≤40 (n=150) and PNI >40 (n=77). We assessed the clinical significance of PNI in terms of the incidence of postoperative infectious complications (PICs) and the postoperative recurrence of CD.
Results: The low PNI group had significantly higher rates of infectious complications (32.0% vs. 10.4%, p=0.001) compared to the high PNI group. Multivariable analysis identified low PNI (≤40) and longer operation time (>180 min) as independent risk factors associated with PICs [odds ratio (OR)=2.754, 95% confidence interval (CI)=1.140-6.649, p=0.024; OR=2.986, 95% CI=1.451-6.143, p=0.003]. PICs were significantly associated with surgical recurrence (hazard ratio=2.217, 95% CI=1.064-4.617, p=0.034).
Conclusion: Preoperative PNI could serve as a predictive factor for PICs in CD patients who undergo intestinal resection. Additionally, PICs are significantly associated with a higher risk of surgical recurrence in CD.
目的:尽管医学治疗取得了进步,但约有一半的肠克罗恩病(CD)患者在其一生中需要进行肠切除手术。众所周知,克罗恩病患者的营养状况会影响术后发病率。本研究旨在评估接受原发性肠切除术的肠道克罗恩病患者预后营养指数(PNI)的临床意义:我们回顾性调查了2005年1月至2018年10月期间在赛文医院确诊为CD并接受肠道手术的患者。患者分为两组:PNI≤40(n=150)和PNI>40(n=77)。我们从术后感染性并发症(PIC)的发生率和CD术后复发率两方面评估了PNI的临床意义:结果:与高 PNI 组相比,低 PNI 组的感染性并发症发生率明显更高(32.0% 对 10.4%,P=0.001)。多变量分析发现,低 PNI(≤40)和较长的手术时间(>180 分钟)是与 PIC 相关的独立风险因素[几率比(OR)=2.754,95% 置信区间(CI)=1.140-6.649,P=0.024;OR=2.986,95% CI=1.451-6.143,P=0.003]。PIC与手术复发明显相关(危险比=2.217,95% CI=1.064-4.617,P=0.034):结论:在接受肠切除术的 CD 患者中,术前 PNI 可作为 PIC 的预测因素。结论:术前 PNI 可作为接受肠切除术的 CD 患者出现 PICs 的预测因素,此外,PICs 与 CD 患者手术复发的较高风险显著相关。
{"title":"Clinical Significance of Prognostic Nutrition Index in Patients with Crohn's Disease after Primary Bowel Resection.","authors":"Hyeon Woo Bae, Yong Joon Lee, Min Young Park, Seung Yoon Yang, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Kang Young Lee, Jae Hee Cheon, Joseph C Carmichael, Byung Soh Min","doi":"10.3349/ymj.2023.0279","DOIUrl":"10.3349/ymj.2023.0279","url":null,"abstract":"<p><strong>Purpose: </strong>Although advancements in medical treatments have been made, approximately half of patients with intestinal Crohn's disease (CD) require intestinal resections during their lifetime. It is well-known that the nutritional status of CD patients can impact postoperative morbidity. The objective of this study was to evaluate the clinical significance of prognostic nutritional index (PNI) in patients with intestinal CD who underwent primary bowel resection.</p><p><strong>Materials and methods: </strong>We retrospectively investigated patients who were diagnosed with CD and underwent intestinal surgery at Severance Hospital between January 2005 and October 2018. The patients were divided into two groups: PNI ≤40 (n=150) and PNI >40 (n=77). We assessed the clinical significance of PNI in terms of the incidence of postoperative infectious complications (PICs) and the postoperative recurrence of CD.</p><p><strong>Results: </strong>The low PNI group had significantly higher rates of infectious complications (32.0% vs. 10.4%, <i>p</i>=0.001) compared to the high PNI group. Multivariable analysis identified low PNI (≤40) and longer operation time (>180 min) as independent risk factors associated with PICs [odds ratio (OR)=2.754, 95% confidence interval (CI)=1.140-6.649, <i>p</i>=0.024; OR=2.986, 95% CI=1.451-6.143, <i>p</i>=0.003]. PICs were significantly associated with surgical recurrence (hazard ratio=2.217, 95% CI=1.064-4.617, <i>p</i>=0.034).</p><p><strong>Conclusion: </strong>Preoperative PNI could serve as a predictive factor for PICs in CD patients who undergo intestinal resection. Additionally, PICs are significantly associated with a higher risk of surgical recurrence in CD.</p>","PeriodicalId":23765,"journal":{"name":"Yonsei Medical Journal","volume":"65 7","pages":"380-388"},"PeriodicalIF":2.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11199177/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jihie Kim, Jae Jun Yang, Jaeha Song, SeongWoon Jo, YoungHoon Kim, Jiho Park, Jin Bog Lee, Gun Woo Lee, Sehan Park
Purpose: This study was conducted to develop a convolutional neural network (CNN) algorithm that can diagnose cervical foraminal stenosis using oblique radiographs and evaluate its accuracy.
Materials and methods: A total of 997 patients who underwent cervical MRI and cervical oblique radiographs within a 3-month interval were included. Oblique radiographs were labeled as "foraminal stenosis" or "no foraminal stenosis" according to whether foraminal stenosis was present in the C2-T1 levels based on MRI evaluation as ground truth. The CNN model involved data augmentation, image preprocessing, and transfer learning using DenseNet161. Visualization of the location of the CNN model was performed using gradient-weight class activation mapping (Grad-CAM).
Results: The area under the curve (AUC) of the receiver operating characteristic curve based on DenseNet161 was 0.889 (95% confidence interval, 0.851-0.927). The F1 score, accuracy, precision, and recall were 88.5%, 84.6%, 88.1%, and 88.5%, respectively. The accuracy of the proposed CNN model was significantly higher than that of two orthopedic surgeons (64.0%, p<0.001; 58.0%, p<0.001). Grad-CAM analysis demonstrated that the CNN model most frequently focused on the foramen location for the determination of foraminal stenosis, although disc space was also frequently taken into consideration.
Conclusion: A CNN algorithm that can detect neural foraminal stenosis in cervical oblique radiographs was developed. The AUC, F1 score, and accuracy were 0.889, 88.5%, and 84.6%, respectively. With the current CNN model, cervical oblique radiography could be a more effective screening tool for neural foraminal stenosis.
{"title":"Detection of Cervical Foraminal Stenosis from Oblique Radiograph Using Convolutional Neural Network Algorithm.","authors":"Jihie Kim, Jae Jun Yang, Jaeha Song, SeongWoon Jo, YoungHoon Kim, Jiho Park, Jin Bog Lee, Gun Woo Lee, Sehan Park","doi":"10.3349/ymj.2023.0091","DOIUrl":"10.3349/ymj.2023.0091","url":null,"abstract":"<p><strong>Purpose: </strong>This study was conducted to develop a convolutional neural network (CNN) algorithm that can diagnose cervical foraminal stenosis using oblique radiographs and evaluate its accuracy.</p><p><strong>Materials and methods: </strong>A total of 997 patients who underwent cervical MRI and cervical oblique radiographs within a 3-month interval were included. Oblique radiographs were labeled as \"foraminal stenosis\" or \"no foraminal stenosis\" according to whether foraminal stenosis was present in the C2-T1 levels based on MRI evaluation as ground truth. The CNN model involved data augmentation, image preprocessing, and transfer learning using DenseNet161. Visualization of the location of the CNN model was performed using gradient-weight class activation mapping (Grad-CAM).</p><p><strong>Results: </strong>The area under the curve (AUC) of the receiver operating characteristic curve based on DenseNet161 was 0.889 (95% confidence interval, 0.851-0.927). The F1 score, accuracy, precision, and recall were 88.5%, 84.6%, 88.1%, and 88.5%, respectively. The accuracy of the proposed CNN model was significantly higher than that of two orthopedic surgeons (64.0%, <i>p</i><0.001; 58.0%, <i>p</i><0.001). Grad-CAM analysis demonstrated that the CNN model most frequently focused on the foramen location for the determination of foraminal stenosis, although disc space was also frequently taken into consideration.</p><p><strong>Conclusion: </strong>A CNN algorithm that can detect neural foraminal stenosis in cervical oblique radiographs was developed. The AUC, F1 score, and accuracy were 0.889, 88.5%, and 84.6%, respectively. With the current CNN model, cervical oblique radiography could be a more effective screening tool for neural foraminal stenosis.</p>","PeriodicalId":23765,"journal":{"name":"Yonsei Medical Journal","volume":"65 7","pages":"389-396"},"PeriodicalIF":2.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11199181/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chae Eun Lee, Ji-Young Kim, Jin Sook Yoon, JaeSang Ko
Purpose: Orbital fibroblasts play key roles in the pathogenesis of Graves' orbitopathy (GO), and previous findings have shown that endoplasmic reticulum (ER) stress and autophagy also contribute to GO. In this study, we investigated the presently unclear roles of inositol-requiring enzyme 1 (IRE1) and related autophagy processes in the pro-fibrotic mechanism of GO.
Materials and methods: Orbital adipose/connective tissues were obtained from eight GO patients and six normal individuals during surgery. GO fibroblasts were transfected with IRE1 small-interfering RNA and treated with bafilomycin A1 (Baf-A1) to evaluate the inhibitory effects of ER stress and autophagy, and protein-expression levels were analyzed through western blotting after stimulation with transforming growth factor (TGF)-β.
Results: TGF-β stimulation upregulated IRE1 in GO orbital fibroblasts, whereas silencing IRE1 suppressed fibrosis and autophagy responses. Similarly, Baf-A1, an inhibitor of late-phase autophagy, decreased the expression of pro-fibrotic proteins.
Conclusion: IRE1 mediates autophagy and the pro-fibrotic mechanism of GO, which provides a more comprehensive interpretation of GO pathogenesis and suggests potential therapeutic targets.
目的:眼眶成纤维细胞在巴塞杜氏眼眶病(Graves' orbitopathy,GO)的发病机制中起着关键作用,以往的研究结果表明,内质网(ER)应激和自噬也是导致GO的原因之一。在本研究中,我们探讨了目前尚不清楚的肌醇请求酶1(IRE1)和相关自噬过程在GO促纤维化机制中的作用:从 8 名 GO 患者和 6 名正常人的手术中获取眼眶脂肪/结缔组织。用IRE1小干扰RNA转染GO成纤维细胞并用巴佛洛霉素A1(Baf-A1)处理,以评估ER应激和自噬的抑制作用,并在转化生长因子(TGF)-β刺激后通过Western印迹分析蛋白表达水平:结果:TGF-β刺激会上调GO眼眶成纤维细胞中的IRE1,而沉默IRE1会抑制纤维化和自噬反应。同样,晚期自噬抑制剂Baf-A1可减少促纤维化蛋白的表达:结论:IRE1介导了GO的自噬和促纤维化机制,这为GO的发病机制提供了更全面的解释,并提出了潜在的治疗靶点。
{"title":"Role of Inositol-Requiring Enzyme 1 and Autophagy in the Pro-Fibrotic Mechanism Underlying Graves' Orbitopathy.","authors":"Chae Eun Lee, Ji-Young Kim, Jin Sook Yoon, JaeSang Ko","doi":"10.3349/ymj.2023.0294","DOIUrl":"10.3349/ymj.2023.0294","url":null,"abstract":"<p><strong>Purpose: </strong>Orbital fibroblasts play key roles in the pathogenesis of Graves' orbitopathy (GO), and previous findings have shown that endoplasmic reticulum (ER) stress and autophagy also contribute to GO. In this study, we investigated the presently unclear roles of inositol-requiring enzyme 1 (IRE1) and related autophagy processes in the pro-fibrotic mechanism of GO.</p><p><strong>Materials and methods: </strong>Orbital adipose/connective tissues were obtained from eight GO patients and six normal individuals during surgery. GO fibroblasts were transfected with IRE1 small-interfering RNA and treated with bafilomycin A1 (Baf-A1) to evaluate the inhibitory effects of ER stress and autophagy, and protein-expression levels were analyzed through western blotting after stimulation with transforming growth factor (TGF)-β.</p><p><strong>Results: </strong>TGF-β stimulation upregulated IRE1 in GO orbital fibroblasts, whereas silencing IRE1 suppressed fibrosis and autophagy responses. Similarly, Baf-A1, an inhibitor of late-phase autophagy, decreased the expression of pro-fibrotic proteins.</p><p><strong>Conclusion: </strong>IRE1 mediates autophagy and the pro-fibrotic mechanism of GO, which provides a more comprehensive interpretation of GO pathogenesis and suggests potential therapeutic targets.</p>","PeriodicalId":23765,"journal":{"name":"Yonsei Medical Journal","volume":"65 7","pages":"397-405"},"PeriodicalIF":2.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11199180/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sun Young Lee, Young Sun Ro, Sang Do Shin, Seong Jung Kim, Eujene Jung
Purpose: As people living with cancer increase in the aging society, cancer-related emergency department (ED) visits are also increasing. This study aimed to investigate the epidemiologic characteristics of non-emergent cancer-related ED visits using a nationwide ED database.
Materials and methods: A cross-sectional study was conducted using the National Emergency Department Information System (NEDIS) database. All cancer-related ED visits between 2016 and 2020 were included. The study outcome was non-emergent ED visits, defined as patients triaged into non-emergent condition at both the time of arrival at ED and discharge from ED and were discharged without hospitalization.
Results: Among 1185871 cancer-related ED visits over 5 years, 19.0% (n=225491) were classified as non-emergent visits. While abdominal pain and fever are the top chief complaints in both emergent and non-emergent visits, non-emergent visits had high proportions of abdomen distension (4.8%), ascite (2.4%), and pain in lower limb (2.0%) compared with emergent visits. The cancer types with a high proportion of non-emergent visits were thyroid (32.4%) and prostate cancer (30.4%). Adults compared with children or older adults, female, medical aid insurance, urban/rural ED, direct-in compared with transfer-in, and weekend visit were associated with high odds for non-emergent visits.
Conclusion: Approximately 20% of cancer-related ED visits may be potentially non-emergent. A significant number of non-emergent patients visited the ED due to cancer-related symptoms. To improve the quality of care for people living with cancer, the expansion of supportive care resources besides of ED, including active symptom control, is necessary.
{"title":"Epidemiology of Non-Emergent Cancer-Related Emergency Department Visits in Korea between 2016 and 2020.","authors":"Sun Young Lee, Young Sun Ro, Sang Do Shin, Seong Jung Kim, Eujene Jung","doi":"10.3349/ymj.2023.0338","DOIUrl":"10.3349/ymj.2023.0338","url":null,"abstract":"<p><strong>Purpose: </strong>As people living with cancer increase in the aging society, cancer-related emergency department (ED) visits are also increasing. This study aimed to investigate the epidemiologic characteristics of non-emergent cancer-related ED visits using a nationwide ED database.</p><p><strong>Materials and methods: </strong>A cross-sectional study was conducted using the National Emergency Department Information System (NEDIS) database. All cancer-related ED visits between 2016 and 2020 were included. The study outcome was non-emergent ED visits, defined as patients triaged into non-emergent condition at both the time of arrival at ED and discharge from ED and were discharged without hospitalization.</p><p><strong>Results: </strong>Among 1185871 cancer-related ED visits over 5 years, 19.0% (n=225491) were classified as non-emergent visits. While abdominal pain and fever are the top chief complaints in both emergent and non-emergent visits, non-emergent visits had high proportions of abdomen distension (4.8%), ascite (2.4%), and pain in lower limb (2.0%) compared with emergent visits. The cancer types with a high proportion of non-emergent visits were thyroid (32.4%) and prostate cancer (30.4%). Adults compared with children or older adults, female, medical aid insurance, urban/rural ED, direct-in compared with transfer-in, and weekend visit were associated with high odds for non-emergent visits.</p><p><strong>Conclusion: </strong>Approximately 20% of cancer-related ED visits may be potentially non-emergent. A significant number of non-emergent patients visited the ED due to cancer-related symptoms. To improve the quality of care for people living with cancer, the expansion of supportive care resources besides of ED, including active symptom control, is necessary.</p>","PeriodicalId":23765,"journal":{"name":"Yonsei Medical Journal","volume":"65 7","pages":"418-426"},"PeriodicalIF":2.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11199182/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hong Jun Lee, Jae Seung Lee, Hyesung So, Ja Kyung Yoon, Jin-Young Choi, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim
Purpose: Nivolumab and regorafenib are second-line therapies for patients with advanced hepatocellular carcinoma (HCC). We aimed to compare the effectiveness of nivolumab and regorafenib.
Materials and methods: We retrospectively reviewed patients with HCC treated with nivolumab or regorafenib after sorafenib failure. Progression-free survival (PFS) and overall survival (OS) were analyzed. An inverse probability of treatment weighting using the propensity score (PS) was performed to reduce treatment selection bias.
Results: Among the 189 patients recruited, 137 and 52 patients received regorafenib and nivolumab after sorafenib failure, respectively. Nivolumab users showed higher Child-Pugh B patients (42.3% vs. 24.1%) and shorter median sorafenib maintenance (2.2 months vs. 3.5 months) compared to regorafenib users. Nivolumab users showed shorter median OS (4.2 months vs. 7.4 months, p=0.045) than regorafenib users and similar median PFS (1.8 months vs. 2.7 months, p=0.070). However, the median overall and PFS did not differ between the two treatment groups after the 1:1 PS matching (log-rank p=0.810 and 0.810, respectively) and after the stabilized inverse probability of treatment weighting (log-rank p=0.445 and 0.878, respectively). In addition, covariate-adjusted Cox regression analyses showed that overall and PFS did not significantly differ between nivolumab and regorafenib users after 1:1 PS matching and stabilized inverse probability of treatment weighting (all p>0.05).
Conclusion: Clinical outcomes of patients treated with nivolumab and regorafenib after sorafenib treatment failure did not differ significantly.
目的:尼韦单抗和瑞戈非尼是晚期肝细胞癌(HCC)患者的二线疗法。我们旨在比较尼伐单抗和瑞戈非尼的疗效:我们回顾性研究了索拉非尼治疗失败后接受 nivolumab 或瑞戈非尼治疗的 HCC 患者。分析了无进展生存期(PFS)和总生存期(OS)。采用倾向评分(PS)对治疗进行反概率加权,以减少治疗选择偏倚:在招募的189名患者中,分别有137名和52名患者在索拉非尼治疗失败后接受了瑞戈非尼和nivolumab治疗。与瑞戈非尼使用者相比,Nivolumab使用者的Child-Pugh B患者比例更高(42.3%对24.1%),索拉非尼维持治疗的中位时间更短(2.2个月对3.5个月)。与瑞戈非尼使用者相比,Nivolumab使用者的中位OS(4.2个月 vs. 7.4个月,p=0.045)更短,中位PFS(1.8个月 vs. 2.7个月,p=0.070)相似。然而,经过1:1 PS匹配(log-rank p=0.810和0.810)和稳定的逆概率治疗加权(log-rank p=0.445和0.878)后,两个治疗组的中位总生存期和PFS没有差异。此外,协变量调整后的Cox回归分析显示,经过1:1 PS匹配和稳定的逆概率治疗加权后,尼伐单抗和瑞戈非尼使用者的总生存期和PFS没有显著差异(均为P>0.05):结论:索拉非尼治疗失败后,接受尼伐单抗和瑞戈非尼治疗的患者的临床结局没有显著差异。
{"title":"Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma.","authors":"Hong Jun Lee, Jae Seung Lee, Hyesung So, Ja Kyung Yoon, Jin-Young Choi, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim","doi":"10.3349/ymj.2023.0263","DOIUrl":"10.3349/ymj.2023.0263","url":null,"abstract":"<p><strong>Purpose: </strong>Nivolumab and regorafenib are second-line therapies for patients with advanced hepatocellular carcinoma (HCC). We aimed to compare the effectiveness of nivolumab and regorafenib.</p><p><strong>Materials and methods: </strong>We retrospectively reviewed patients with HCC treated with nivolumab or regorafenib after sorafenib failure. Progression-free survival (PFS) and overall survival (OS) were analyzed. An inverse probability of treatment weighting using the propensity score (PS) was performed to reduce treatment selection bias.</p><p><strong>Results: </strong>Among the 189 patients recruited, 137 and 52 patients received regorafenib and nivolumab after sorafenib failure, respectively. Nivolumab users showed higher Child-Pugh B patients (42.3% vs. 24.1%) and shorter median sorafenib maintenance (2.2 months vs. 3.5 months) compared to regorafenib users. Nivolumab users showed shorter median OS (4.2 months vs. 7.4 months, <i>p</i>=0.045) than regorafenib users and similar median PFS (1.8 months vs. 2.7 months, <i>p</i>=0.070). However, the median overall and PFS did not differ between the two treatment groups after the 1:1 PS matching (log-rank <i>p</i>=0.810 and 0.810, respectively) and after the stabilized inverse probability of treatment weighting (log-rank <i>p</i>=0.445 and 0.878, respectively). In addition, covariate-adjusted Cox regression analyses showed that overall and PFS did not significantly differ between nivolumab and regorafenib users after 1:1 PS matching and stabilized inverse probability of treatment weighting (all <i>p</i>>0.05).</p><p><strong>Conclusion: </strong>Clinical outcomes of patients treated with nivolumab and regorafenib after sorafenib treatment failure did not differ significantly.</p>","PeriodicalId":23765,"journal":{"name":"Yonsei Medical Journal","volume":"65 7","pages":"371-379"},"PeriodicalIF":2.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11199178/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eda Ureyen Ozdemir, Gul Nihal Buyuk, Esin Merve Erol Koc, Goksun Ipek, Ulku Gurbuz Ozbebek, Muslume Asli Gurun, Necati Hancerliogullari
Purpose: The C-reactive protein/albumin ratio (CAR) has been reported as a novel inflammatory marker to assess inflammation. The aim of this study was to compare the levels of CAR as a inflammatory marker in gestational diabetes mellitus (GDM) and non GDM patients.
Materials and methods: Eight hundred ten pregnant women who applied to our hospital for routine antenatal screening were included in this prospective case-control study. The patients were divided into two groups, as positive and negative diagnosis of GDM. CAR between groups was compared as the primary outcome using statistical methods.
Results: The CAR value was significantly higher in pregnancies with GDM compared to healthy controls [1.07 (0.43-1.89) vs. 0.37 (0.12-0.68), p<0.0001]. The Spearman's correlation analysis revealed that the CAR value had a significant positive correlation with all three steps of 75 gr oral glucose tolerance test (p<0.0001 for each) and neutrophil to lymphocyte ratio value (p=0.011).
Conclusion: Considering that laboratory testing is very simple and inexpensive, CAR is an independent predictor that is clinically easy to use for the development of GDM. This report is the first to show the role of CAR in GDM. However, further studies with larger sample sizes are needed to generalize this comment.
目的:据报道,C反应蛋白/白蛋白比值(CAR)是评估炎症的一种新型炎症标志物。本研究旨在比较妊娠期糖尿病(GDM)患者和非 GDM 患者中作为炎症标志物的 CAR 水平:这项前瞻性病例对照研究纳入了在本医院接受常规产前筛查的 81 名孕妇。患者被分为两组,即 GDM 诊断阳性组和阴性组。研究采用统计学方法比较两组间的 CAR 值,并将其作为主要结果:结果:与健康对照组相比,GDM 孕妇的 CAR 值明显更高[1.07 (0.43-1.89) vs. 0.37 (0.12-0.68), ppp=0.011]:考虑到实验室检测非常简单且成本低廉,CAR 是一种独立的预测指标,在临床上易于用于预测 GDM 的发生。本报告首次显示了 CAR 在 GDM 中的作用。然而,要推广这一观点,还需要更多样本量的进一步研究。
{"title":"Gestational Diabetes and C-Reactive Protein/Albumin Ratio in Pregnancy: A Prospective Study.","authors":"Eda Ureyen Ozdemir, Gul Nihal Buyuk, Esin Merve Erol Koc, Goksun Ipek, Ulku Gurbuz Ozbebek, Muslume Asli Gurun, Necati Hancerliogullari","doi":"10.3349/ymj.2023.0334","DOIUrl":"10.3349/ymj.2023.0334","url":null,"abstract":"<p><strong>Purpose: </strong>The C-reactive protein/albumin ratio (CAR) has been reported as a novel inflammatory marker to assess inflammation. The aim of this study was to compare the levels of CAR as a inflammatory marker in gestational diabetes mellitus (GDM) and non GDM patients.</p><p><strong>Materials and methods: </strong>Eight hundred ten pregnant women who applied to our hospital for routine antenatal screening were included in this prospective case-control study. The patients were divided into two groups, as positive and negative diagnosis of GDM. CAR between groups was compared as the primary outcome using statistical methods.</p><p><strong>Results: </strong>The CAR value was significantly higher in pregnancies with GDM compared to healthy controls [1.07 (0.43-1.89) vs. 0.37 (0.12-0.68), <i>p</i><0.0001]. The Spearman's correlation analysis revealed that the CAR value had a significant positive correlation with all three steps of 75 gr oral glucose tolerance test (<i>p</i><0.0001 for each) and neutrophil to lymphocyte ratio value (<i>p</i>=0.011).</p><p><strong>Conclusion: </strong>Considering that laboratory testing is very simple and inexpensive, CAR is an independent predictor that is clinically easy to use for the development of GDM. This report is the first to show the role of CAR in GDM. However, further studies with larger sample sizes are needed to generalize this comment.</p>","PeriodicalId":23765,"journal":{"name":"Yonsei Medical Journal","volume":"65 7","pages":"413-417"},"PeriodicalIF":2.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11199176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}